Correlation Between Innate Pharma and Neovacs SA
Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Neovacs SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Neovacs SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innate Pharma and Neovacs SA, you can compare the effects of market volatilities on Innate Pharma and Neovacs SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Neovacs SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Neovacs SA.
Diversification Opportunities for Innate Pharma and Neovacs SA
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Innate and Neovacs is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Neovacs SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neovacs SA and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Neovacs SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neovacs SA has no effect on the direction of Innate Pharma i.e., Innate Pharma and Neovacs SA go up and down completely randomly.
Pair Corralation between Innate Pharma and Neovacs SA
Assuming the 90 days trading horizon Innate Pharma is expected to under-perform the Neovacs SA. But the stock apears to be less risky and, when comparing its historical volatility, Innate Pharma is 6.5 times less risky than Neovacs SA. The stock trades about -0.2 of its potential returns per unit of risk. The Neovacs SA is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 0.02 in Neovacs SA on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Neovacs SA or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Innate Pharma vs. Neovacs SA
Performance |
| Timeline |
| Innate Pharma |
| Neovacs SA |
Innate Pharma and Neovacs SA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Innate Pharma and Neovacs SA
The main advantage of trading using opposite Innate Pharma and Neovacs SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Neovacs SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neovacs SA will offset losses from the drop in Neovacs SA's long position.| Innate Pharma vs. Biomerieux SA | Innate Pharma vs. Eurofins Scientific SE | Innate Pharma vs. Sartorius Stedim Biotech | Innate Pharma vs. SEB SA |
| Neovacs SA vs. Biomerieux SA | Neovacs SA vs. Eurofins Scientific SE | Neovacs SA vs. Sartorius Stedim Biotech | Neovacs SA vs. SEB SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |